W

Wai Yuen Tong Medicine Holdings Ltd
HKEX:897

Watchlist Manager
Wai Yuen Tong Medicine Holdings Ltd
HKEX:897
Watchlist
Price: 0.227 HKD Market Closed
Updated: May 22, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

232.6m
+40%
Operating Cash Flow
Growth Rates:
1 Year
+28%
3 Years
+2%
5 Years
-
7 Years
-
10 Years
-
90.2m
+314%
Investing Cash Flow
Growth Rates:
1 Year
+11%
3 Years
-78%
5 Years
-
7 Years
-
10 Years
-
-443.7m
-179%
Financing Cash Flow
Growth Rates:
1 Year
-148%
3 Years
-99%
5 Years
-
7 Years
-
10 Years
-

Cash Flow Statement
Wai Yuen Tong Medicine Holdings Ltd

Rotate your device to view
Cash Flow Statement
Currency: HKD
Mar-2005 Sep-2005 Mar-2006 Sep-2006 Mar-2007 Sep-2007 Mar-2008 Sep-2008 Mar-2009 Sep-2009 Mar-2010 Sep-2010 Mar-2011 Sep-2011 Mar-2012 Sep-2012 Mar-2013 Sep-2013 Mar-2014 Sep-2014 Mar-2015 Sep-2015 Mar-2016 Sep-2016 Mar-2017 Sep-2017 Mar-2018 Sep-2018 Mar-2019 Sep-2019 Mar-2020 Sep-2020 Mar-2021 Sep-2021 Mar-2022 Sep-2022 Mar-2023 Sep-2023
Operating Cash Flow
Net Income
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
172
0
121
0
29
0
(96)
0
(115)
0
82
0
455
0
(303)
0
(47)
0
(12)
0
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19
0
15
0
15
0
14
0
47
0
51
0
113
0
93
0
108
0
113
0
Other Non-Cash Items
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(141)
0
(163)
0
(91)
0
(8)
0
24
0
(203)
0
(545)
0
397
0
234
0
144
0
Cash Taxes Paid
4
0
2
0
(0)
0
2
0
4
0
1
0
12
0
9
0
0
0
1
(7)
(0)
6
2
2
2
2
(2)
(2)
1
7
13
52
90
92
82
61
53
47
Cash Interest Paid
2
0
8
0
6
0
3
0
3
0
2
0
1
0
2
0
0
0
8
5
10
13
15
16
17
19
19
23
29
34
45
84
84
62
58
69
86
85
Change in Working Capital
(49)
(32)
(9)
10
124
114
(23)
(21)
18
42
40
18
(107)
(92)
34
31
(10)
(31)
(35)
39
84
(93)
(69)
(41)
0
(46)
(32)
(77)
43
(76)
(55)
217
226
183
(143)
182
(79)
233
Cash from Operating Activities
(49)
N/A
(32)
+34%
(9)
+72%
10
N/A
124
+1 147%
114
-8%
(23)
N/A
(21)
+10%
18
N/A
42
+138%
40
-3%
18
-56%
(107)
N/A
(92)
+14%
34
N/A
31
-9%
(10)
N/A
(31)
-209%
15
N/A
39
+156%
58
+47%
(93)
N/A
(116)
-24%
(41)
+65%
(90)
-121%
(46)
+49%
(77)
-67%
(77)
+0%
(27)
+65%
(76)
-184%
(33)
+57%
229
N/A
413
+80%
194
-53%
152
-22%
182
+20%
166
-9%
233
+40%
Investing Cash Flow
Capital Expenditures
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(56)
(82)
(285)
(278)
(282)
(94)
(78)
(77)
(64)
(52)
(17)
(16)
(7)
(18)
(60)
(53)
(26)
(33)
(33)
(59)
Other Items
(227)
(102)
(44)
(53)
84
81
(368)
(377)
(5)
(15)
(8)
(40)
(225)
(234)
(57)
15
(47)
(230)
(136)
(6)
(149)
(231)
(43)
(194)
(114)
(51)
87
(28)
(86)
41
432
428
(5)
3
48
115
55
150
Cash from Investing Activities
(227)
N/A
(102)
+55%
(44)
+57%
(53)
-19%
84
N/A
81
-4%
(368)
N/A
(377)
-3%
(5)
+99%
(15)
-206%
(8)
+47%
(40)
-401%
(225)
-467%
(234)
-4%
(57)
+76%
15
N/A
(47)
N/A
(230)
-388%
(191)
+17%
(87)
+54%
(435)
-399%
(509)
-17%
(325)
+36%
(288)
+11%
(192)
+33%
(128)
+33%
23
N/A
(80)
N/A
(103)
-29%
26
N/A
425
+1 554%
410
-4%
(64)
N/A
(50)
+23%
22
N/A
82
+268%
22
-73%
90
+314%
Financing Cash Flow
Net Issuance of Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
109
202
321
228
180
408
0
0
(7)
(10)
(3)
0
0
0
0
0
(10)
(10)
(15)
Net Issuance of Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
128
75
159
129
189
179
21
(60)
168
215
(75)
(38)
(36)
(139)
(266)
(84)
(90)
(99)
(52)
(290)
Cash Paid for Dividends
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(9)
(9)
(9)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other
291
79
118
88
(79)
304
254
(169)
(55)
23
(8)
30
397
355
13
(11)
274
357
(8)
32
(16)
(1)
(20)
186
(24)
(18)
(18)
(22)
(29)
(34)
(45)
(84)
(84)
(101)
(115)
(70)
(97)
(139)
Cash from Financing Activities
291
N/A
79
-73%
118
+49%
88
-26%
(79)
N/A
304
N/A
254
-17%
(169)
N/A
(55)
+68%
23
N/A
(8)
N/A
30
N/A
397
+1 242%
355
-11%
13
-96%
(11)
N/A
274
N/A
357
+30%
112
-69%
207
+85%
336
+63%
448
+33%
396
-12%
545
+38%
405
-26%
(78)
N/A
150
N/A
186
+24%
(113)
N/A
(74)
+34%
(82)
-10%
(223)
-173%
(351)
-57%
(185)
+47%
(204)
-11%
(179)
+12%
(159)
+11%
(444)
-179%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
(0)
0
(1)
(1)
0
0
0
2
2
1
0
0
0
0
0
(0)
(1)
(0)
(0)
(4)
1
1
(10)
(7)
0
(7)
17
34
17
33
(16)
(12)
(7)
Net Change in Cash
16
N/A
(55)
N/A
65
N/A
46
-30%
129
+183%
499
+288%
(137)
N/A
(567)
-315%
(43)
+92%
50
N/A
24
-52%
8
-67%
67
+752%
32
-53%
(9)
N/A
35
N/A
217
+512%
97
-55%
(64)
N/A
159
N/A
(42)
N/A
(155)
-272%
(45)
+71%
217
N/A
118
-45%
(252)
N/A
97
N/A
20
-80%
(250)
N/A
(124)
+50%
304
N/A
432
+42%
32
-93%
(23)
N/A
3
N/A
69
+2 265%
17
-76%
(128)
N/A
Free Cash Flow
Free Cash Flow
(49)
N/A
(32)
+34%
(9)
+72%
10
N/A
124
+1 147%
114
-8%
(23)
N/A
(21)
+10%
18
N/A
42
+138%
40
-3%
18
-56%
(107)
N/A
(92)
+14%
34
N/A
31
-9%
(10)
N/A
(31)
-209%
(40)
-32%
(42)
-5%
(228)
-437%
(371)
-63%
(398)
-7%
(135)
+66%
(168)
-25%
(123)
+27%
(140)
-14%
(128)
+9%
(44)
+66%
(91)
-110%
(39)
+57%
211
N/A
353
+68%
141
-60%
126
-11%
149
+18%
132
-11%
173
+31%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 139,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.